News | June 06, 2026
Alembic Pharma receives USFDA approval for Haloperidol tablets
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Healthcare industry leader returns to India to support Apollo Hospitals’ global expansion and advance the ‘Heal in India, Heal by India’ vision
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The trial results are for the pharma powerhouse's RET-targeted therapy Retevmo (selpercatinib)
Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru
Subscribe To Our Newsletter & Stay Updated
